NCT01643278 2017-01-10Dasatinib and Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumors or Other Sarcomas That Cannot Be Removed by Surgery or Are MetastaticNational Cancer Institute (NCI)Phase 1 Completed29 enrolled